$HCWC
HEALTHY CHOICE WELLNESS CORP. Stock $hcwc

$hcwc Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000149315224045161 Filed on November 13, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2024 Q2
Revenue		$18.23M	$15.59M
YoY Change		43.49%
Cost Of Revenue		$11.23M	$9.698M
YoY Change		39.27%
Gross Profit		$7.002M	$5.896M
YoY Change		50.82%
Gross Profit Margin		38.41%	37.81%
Selling, General & Admin		$7.579M
YoY Change		28.51%
% of Gross Profit		108.25%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$423.2K	$361.8K
YoY Change
% of Gross Profit		6.04%	6.14%
Operating Expenses		$7.374M	$6.378M
YoY Change		25.03%
Operating Profit		-$372.4K	-$481.6K
YoY Change		-70.33%
Interest Expense		-$396.7K	-$118.0K
YoY Change		915.3%
% of Operating Profit
Other Income/Expense, Net		-$2.286M	$3.830K
YoY Change		-781.47%
Pretax Income		-$2.659M	-$595.7K
YoY Change		189.07%
Income Tax			$0.00
% Of Pretax Income
Net Earnings		-$2.659M	-$595.7K
YoY Change		189.07%
Net Earnings / Revenue		-14.58%	-3.82%
Basic Earnings Per Share		-$0.29
Diluted Earnings Per Share		-$0.29	-$0.06
COMMON SHARES
Basic Shares Outstanding	9.816M shares	9.309M shares
Diluted Shares Outstanding		9.309M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.787M	$964.3K
YoY Change
Cash & Equivalents	$1.800M
Short-Term Investments
Other Short-Term Assets	$90.87K	$827.6K
YoY Change
Inventory	$6.402M	$3.931M
Prepaid Expenses
Receivables	$339.9K	$157.3K
Other Receivables	$106.8K	$0.00
Total Short-Term Assets	$9.011M	$5.880M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$2.002M	$11.96M
YoY Change
Goodwill	$2.212M
YoY Change
Intangibles	$5.738M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$550.5K	$474.5K
YoY Change
Total Long-Term Assets	$24.17M	$21.97M
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$9.011M	$5.880M
Total Long-Term Assets	$24.17M	$21.97M
Total Assets	$33.18M	$27.85M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.280M	$3.770M
YoY Change
Accrued Expenses	$4.121M	$3.246M
YoY Change
Deferred Revenue	$49.54K
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.883M	$2.495M
YoY Change
Total Short-Term Liabilities	$10.33M	$9.635M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt	$9.698M	$2.036M
YoY Change
Other Long-Term Liabilities	$10.22M	$7.179M
YoY Change
Total Long-Term Liabilities	$9.698M	$9.216M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.33M	$9.635M
Total Long-Term Liabilities	$9.698M	$9.216M
Total Liabilities	$30.25M	$18.85M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings	-$180.1K
YoY Change
Common Stock	$9.816K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.931M	$8.997M
YoY Change
Total Liabilities & Shareholders Equity	$33.18M	$27.85M
YoY Change

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$2.659M	-$595.7K
YoY Change	189.07%
Depreciation, Depletion And Amortization	$423.2K	$361.8K
YoY Change
Cash From Operating Activities	-$963.0K	-$452.8K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures	$28.70K	$42.76K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$4.726M
YoY Change
Cash From Investing Activities	-$4.755M	-$42.76K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	6.540M	436.5K
YoY Change
NET CHANGE
Cash From Operating Activities	-963.0K	-452.8K
Cash From Investing Activities	-4.755M	-42.76K
Cash From Financing Activities	6.540M	436.5K
Net Change In Cash	822.5K	-59.00K
YoY Change
FREE CASH FLOW
Cash From Operating Activities	-$963.0K	-$452.8K
Capital Expenditures	$28.70K	$42.76K
Free Cash Flow	-$991.7K	-$495.5K
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001948864
CY2023Q4	us-gaap	Goodwill Goodwill		usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue		usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital		usd
CY2024Q3	HCWC	Net Investment By Former Parent NetInvestmentByFormerParent		usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit		usd
CY2023Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2024Q3	HCWC	Change In Contingent Consideration ChangeInContingentConsideration		usd
	HCWC	Change In Contingent Consideration ChangeInContingentConsideration		usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q3	HCWC	Stock Issued During Period Value New Issues One StockIssuedDuringPeriodValueNewIssuesOne		usd
	HCWC	Stock Issued During Period Value New Issues One StockIssuedDuringPeriodValueNewIssuesOne		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense		usd
	HCWC	Change In Consideration ChangeInConsideration		usd
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross		usd
	us-gaap	Proceeds From Sale Of Buildings ProceedsFromSaleOfBuildings		usd
	us-gaap	Proceeds From Repayment Of Loans To Purchase Common Stock ProceedsFromRepaymentOfLoansToPurchaseCommonStock		usd
	HCWC	Proceeds From Acquisition Loan ProceedsFromAcquisitionLoan		usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	HCWC	Promissory Note Related To Acquisition PromissoryNoteRelatedToAcquisition		usd
CY2023Q4	us-gaap	Goodwill Goodwill		usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2023Q4	us-gaap	Goodwill Goodwill		usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount		usd
	us-gaap	Debt Instrument Term DebtInstrumentTerm	P5Y
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-42274
	dei	Entity Registrant Name EntityRegistrantName	HEALTHY CHOICE WELLNESS CORP.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	88-4128927
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3800 North 28th Way
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Unit# 1
	dei	Entity Address City Or Town EntityAddressCityOrTown	Hollywood
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33020
	dei	City Area Code CityAreaCode	305
	dei	Local Phone Number LocalPhoneNumber	600-5004
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
	dei	Trading Symbol TradingSymbol	HCWC
	dei	Security Exchange Name SecurityExchangeName	NYSEAMER
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	9815749	shares
	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.001
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1786707	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1422580	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	339876	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	128171	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	6402056	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	4162218	usd
CY2024Q3	HCWC	Prepaid Expenses And Vendor Deposits PrepaidExpensesAndVendorDeposits	284816	usd
CY2023Q4	HCWC	Prepaid Expenses And Vendor Deposits PrepaidExpensesAndVendorDeposits	174970	usd
CY2024Q3	us-gaap	Other Assets Current OtherAssetsCurrent	90866	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	56842	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	9011162	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	5944781	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2002128	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2676639	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5738006	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4178519	usd
CY2024Q3	us-gaap	Goodwill Goodwill	2212000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	13668290	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	11412562	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	550538	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	467056	usd
CY2024Q3	us-gaap	Assets Assets	33182124	usd
CY2023Q4	us-gaap	Assets Assets	28432560	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	5041557	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	4920411	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	49540	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	207513	usd
CY2024Q3	us-gaap	Loans Payable Current LoansPayableCurrent	1882598	usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	702701	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3360002	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2748824	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	10333697	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8579449	usd
CY2024Q3	us-gaap	Long Term Loans Payable LongTermLoansPayable	9698047	usd
CY2023Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	2403807	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	10219591	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8461182	usd
CY2024Q3	us-gaap	Liabilities Liabilities	30251335	usd
CY2023Q4	us-gaap	Liabilities Liabilities	19444438	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	560000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	560000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9815749	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9815749	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	9816	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3101092	usd
CY2023Q4	HCWC	Net Investment By Former Parent NetInvestmentByFormerParent	8988122	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-180119	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	2930789	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8988122	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	33182124	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	28432560	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18229463	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12704600	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	49718396	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	39839202	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	11227644	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	8061966	usd
	us-gaap	Cost Of Revenue CostOfRevenue	30765744	usd
	us-gaap	Cost Of Revenue CostOfRevenue	25199879	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	7001819	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	4642634	usd
	us-gaap	Gross Profit GrossProfit	18952652	usd
	us-gaap	Gross Profit GrossProfit	14639323	usd
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7579388	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	5897769	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	20613526	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	17743763	usd
CY2024Q3	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	205146	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	205146	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	7374242	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	5897769	usd
	us-gaap	Operating Expenses OperatingExpenses	20408380	usd
	us-gaap	Operating Expenses OperatingExpenses	17743763	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-372423	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1255135	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1455728	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3104440	usd
CY2024Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1888889	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1888889	usd
CY2023Q3	HCWC	Change In Contingent Consideration ChangeInContingentConsideration	372000	usd
	HCWC	Change In Contingent Consideration ChangeInContingentConsideration	774900	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-486	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2535	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6697	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	11785	usd
CY2024Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-396709	usd
CY2023Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-39073	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-617758	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-123197	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2286084	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	335462	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2499950	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	663488	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2658507	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-919673	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3955678	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2440952	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-2658507	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-919673	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3955678	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2440952	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9308866	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9308866	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9226860	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9226860	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9254394	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9254394	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9226860	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9226860	shares
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	8997032	usd
CY2024Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2580000	usd
CY2024Q3	HCWC	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	1890778	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-7878514	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-2658507	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	2930789	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	15486920	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	566188	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-919673	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	15133435	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8988122	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2580000	usd
	HCWC	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	1890778	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-6572433	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3955678	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	2930789	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15505661	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15505661	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	2068726	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2440952	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	15133435	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	15133435	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3955678	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2440952	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1148158	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1070686	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1888889	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	205146	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2353880	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1687522	usd
	us-gaap	Inventory Write Down InventoryWriteDown	2157287	usd
	us-gaap	Inventory Write Down InventoryWriteDown	1581043	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-115944	usd
	HCWC	Change In Consideration ChangeInConsideration	774900	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	211705	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	75677	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1997075	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1317816	usd
	HCWC	Increase Decrease In Prepaid Expenses And Vendor Deposits IncreaseDecreaseInPrepaidExpensesAndVendorDeposits	109846	usd
	HCWC	Increase Decrease In Prepaid Expenses And Vendor Deposits IncreaseDecreaseInPrepaidExpensesAndVendorDeposits	41034	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	34024	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-48336	usd
	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	2638730	usd
	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	542718	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	83482	usd
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	3060	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5201	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-119384	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-157972	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-53745	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-2240021	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-1592729	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3964320	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2574428	usd
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	5475000	usd
	us-gaap	Proceeds From Sale Of Buildings ProceedsFromSaleOfBuildings	749000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	145680	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	173475	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4871680	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-173475	usd
	us-gaap	Proceeds From Repayment Of Loans To Purchase Common Stock ProceedsFromRepaymentOfLoansToPurchaseCommonStock	1700000	usd
	us-gaap	Payments Of Loan Costs PaymentsOfLoanCosts	2294221	usd
	us-gaap	Payments Of Loan Costs PaymentsOfLoanCosts	399590	usd
	HCWC	Proceeds From Acquisition Loan ProceedsFromAcquisitionLoan	7500000	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	2580000	usd
	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	1736412	usd
	us-gaap	Proceeds From Contributions From Parent ProceedsFromContributionsFromParent	2068725	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	2023953	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1889	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9200127	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1669135	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	364127	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1078768	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1422580	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2020571	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1786707	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	941803	usd
	us-gaap	Interest Paid Net InterestPaidNet	513605	usd
	us-gaap	Interest Paid Net InterestPaidNet	123221	usd
	HCWC	Promissory Note Related To Acquisition PromissoryNoteRelatedToAcquisition	1825000	usd
	HCWC	Rightofuse Assets Obtained In Exchange For Operating Lease Liabilities RightofuseAssetsObtainedInExchangeForOperatingLeaseLiabilities	4609608	usd
	HCWC	Rightofuse Assets Obtained In Exchange For Operating Lease Liabilities RightofuseAssetsObtainedInExchangeForOperatingLeaseLiabilities	1137786	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_807_eus-gaap--NatureOfOperations_zLPe2B7tlcj1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1. <span id="xdx_82B_zYVSJsJcy4Me">ORGANIZATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Organization</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Healthy Choice Wellness Corp. (the “Company” or “HCWC” or “we” or “our” or “us”) is a holding company focused on providing consumers with healthier daily choices with respect to nutrition and other lifestyle alternatives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through its wholly owned subsidiaries, the Company operates:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ada’s Natural Market, a natural and organic grocery store offering fresh produce, bulk foods, vitamins and supplements, packaged groceries, meat and seafood, deli, baked goods, dairy products, frozen foods, health & beauty products and natural household items.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paradise Health & Nutrition’s three stores that likewise offer fresh produce, bulk foods, vitamins and supplements, packaged groceries, meat and seafood, deli, baked goods, dairy products, frozen foods, health & beauty products and natural household items.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mother Earth’s Storehouse, a two-store organic and health food and vitamin chain in New York’s Hudson Valley, which has been in existence for over 40 years.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Greens Natural Foods’ eight stores in New York and New Jersey, offering a selection of 100% organic produce and all-natural, non-GMO groceries & bulk foods; a wide selection of local products; an organic juice and smoothie bar; a fresh foods department, which offers fresh and healthy “grab & go” foods; a full selection of vitamins & supplements; as well as health and beauty products.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ellwood Thompson’s, an organic and natural health food and vitamin store located in Richmond, Virginia.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">GreenAcres Market, an organic and natural health food and vitamin chain with five store locations in Kansas and Oklahoma. GreenAcres Market offers organic and all natural products and vitamins from both top national brands as well as locally sourced specialty brands.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through its wholly owned subsidiary, Healthy Choice Wellness, LLC, the Company operates a Healthy Choice Wellness Center in Kingston, NY and has a licensing agreement for a Healthy Choice Wellness Center located at the Casbah Spa and Salon in Fort Lauderdale, FL.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These centers offer multiple vitamin drip mixes and intramuscular shots for clients to choose from that are designed to help boost immunity, fight fatigue and stress, reduce inflammation, enhance weight loss, and efficiently deliver antioxidants and anti-aging mixes. Additionally, there are IV vitamin mixes and shots for health, beauty, and re-hydration.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through its wholly owned subsidiary, Healthy U Wholesale, the Company sells vitamins and supplements, as well as health, beauty, and personal care products on its website <span style="text-decoration: underline">www.TheVitaminStore.com</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sourcing and Vendors</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We source from multiple suppliers. These suppliers range from small independent businesses to multinational conglomerates. For the three months ended September 30, 2024 and 2023, approximately <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20240930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--OneVendorMember_zT0qFbnoZoNb" title="Concentration risk percentage">21</span>% and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--OneVendorMember_zmOsAtYKOPU5" title="Concentration risk percentage">40</span>% of our total purchases were from one vendor. For the nine months ended September 30, 2024 and 2023, approximately <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--OneVendorMember_zN6xI3PrBmf6" title="Concentration risk percentage">30</span>% and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--OneVendorMember_zTdm2SIxZDBj" title="Concentration risk percentage">42</span>% of our total purchases were from one vendor.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Spin-Off</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Healthier Choices Management Corp. (“HCMC” or the “Parent”) announced on August 22, 2022 that its Board of Directors approved the separation of the grocery business, including wellness business, into an independent, publicly traded company (the “Spin-Off” or “Separation”). Prior to the Spin-Off, HCWC was a subsidiary under HCMC, which operated the Ada’s Natural Market, Paradise Health & Nutrition, Mother Earth’s Storehouse, Greens Natural Foods, Ellwood Thompson’s, and GreenAcres Market retail brands, as well as licensed wellness centers and Healthy U Wholesale.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 13, 2024 (the “Spin-Off Date”), after the New York Stock Exchange American (“NYSEAM”) market closing, the Spin-Off of the HCWC business was completed. On September 14, 2024, HCWC became an independent, publicly traded company, and on September 16, 2024, the stock commenced trading on the NYSEAM under the stock symbol “HCWC.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">HCMC distributed all the outstanding shares of common stock held by it on a pro rata basis to holders of HCMC’s common stock. For each <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20240908__20240909__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--HealthierChoicesManagementCorpMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ztikdE40ImV8" title="Number of shares issued">208,632</span> shares of HCMC common stock held as of 5:00 p.m., New York City time, on September 9, 2024, the record date for the Spin-Off (the “Record Date”), a HCMC stockholder was entitled to receive one (1) share of Class A common stock and three (3) shares of Class B common stock. The Distribution was made in book-entry form by a distribution agent as soon as practicable after the date of the Distribution.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">HCMC has secured binding commitments of $<span id="xdx_909_ecustom--EquityFinancing_iI_pn4n6_c20240913__dei--LegalEntityAxis__custom--HealthierChoicesManagementCorpMember_zb1WGioDIQKc" title="Equity financing">13.25</span> million in equity financing for HCWC from the same group of investors that invested $<span id="xdx_90D_eus-gaap--Investments_iI_pn4n6_c20240913__dei--LegalEntityAxis__custom--HealthierChoicesManagementCorpMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zcdAlKE0sTb3" title="Investments">13.25</span> million in HCMC Series E Preferred Stock. Pursuant to the Securities Purchase Agreement for the HCMC Series E Stock (“HCMC Series E SPA”), the purchasers of HCMC Series E Stock will also be required to purchase Series A Preferred Stock of HCWC in the same subscription amounts that the Purchasers paid for the HCMC Series E Stock (regardless of whether or not such HCMC Series E Stock has been converted into HCMC common stock).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span> </p>
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1800000	usd
CY2024Q3	HCWC	Working Capital WorkingCapital	1300000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4000000.0	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4000000.0	usd
CY2024Q3	us-gaap	Partners Capital Account Private Placement Of Units PartnersCapitalAccountPrivatePlacementOfUnits	7500000	usd
CY2024Q3	HCWC	Purchase Of Green Acres Market PurchaseOfGreenAcresMarket	4200000	usd
CY2024Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	7500000	usd
CY2024Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.12	pure
CY2024Q3	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2027-07-17
CY2022Q3	us-gaap	Preferred Stock Shares Subscribed But Unissued Value PreferredStockSharesSubscribedButUnissuedValue	13250000	usd
CY2022Q3	us-gaap	Preferred Stock Shares Subscribed But Unissued Value PreferredStockSharesSubscribedButUnissuedValue	13250000	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	13250000	usd
CY2022Q3	us-gaap	Preferred Stock Shares Subscribed But Unissued Value PreferredStockSharesSubscribedButUnissuedValue	13250000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_840_eus-gaap--UseOfEstimates_zAK15Szbmhj4" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_860_zI6OPTzFv998">Use of Estimates in the Preparation of the Financial Statements</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of net revenue and expenses during the reporting periods. Actual results could differ from those estimates. These estimates and assumptions include promotional discounts, manufacturer coupons and rebates, return allowances that are netted against revenue, useful lives and impairment of long-lived assets, allowance for credit losses, inventory provisions, deferred taxes and related valuation allowances, allocation of corporate general expenses, and the valuation of the assets and liabilities acquired in business combinations. Certain of management’s estimates could be affected by external conditions, including those unique to our industry, and general economic conditions. It is possible that these external factors could have an effect on our estimates that could cause actual results to differ from our estimates. The Company re-evaluates all its accounting estimates at least quarterly based on these conditions and records adjustments when necessary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	515353	usd
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	161644	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	6104000	usd
CY2024Q3	us-gaap	Advertising Expense AdvertisingExpense	154000	usd
CY2023Q3	us-gaap	Advertising Expense AdvertisingExpense	215000	usd
	us-gaap	Advertising Expense AdvertisingExpense	356000	usd
	us-gaap	Advertising Expense AdvertisingExpense	366000	usd
CY2024Q3	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	23000	usd
CY2023Q3	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	21000	usd
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	59000	usd
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	59000	usd
CY2024Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	9200000	shares
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-2658507	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-919673	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3955678	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2440952	usd
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9308866	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9308866	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9226860	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9226860	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9254394	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9254394	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9226860	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9226860	shares
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.29
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.43
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.43
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2024Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2024Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2024Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q3	us-gaap	Cash Uninsured Amount CashUninsuredAmount	515353	usd
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	161644	usd
CY2024Q3	us-gaap	Cash Cash	1786707	usd
CY2023Q3	us-gaap	Cash Cash	941803	usd
CY2024Q3	HCWC	Advertising Revenue AdvertisingRevenue	294000	usd
CY2023Q3	HCWC	Advertising Revenue AdvertisingRevenue	68000	usd
	HCWC	Advertising Revenue AdvertisingRevenue	473000	usd
	HCWC	Advertising Revenue AdvertisingRevenue	206000	usd
CY2024Q3	us-gaap	Accounts Receivable Net AccountsReceivableNet	340000	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	128000	usd
	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	26000	usd
CY2023	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	15000	usd
CY2024Q3	us-gaap	Inventory Write Down InventoryWriteDown	673000	usd
CY2023Q3	us-gaap	Inventory Write Down InventoryWriteDown	630000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	2157000	usd
	us-gaap	Inventory Write Down InventoryWriteDown	1581000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	18229463	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	12704600	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	49718396	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	39839202	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3838355	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	4140367	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1836227	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1463728	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2002128	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2676639	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	9435000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-3696994	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5738006	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7131000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-2952481	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4178519	usd
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	284000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	221000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	745000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	663000	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	296528	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1180613	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1103576	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	964771	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	655332	usd
CY2024Q3	HCWC	Finite Lived Intangible Assets Amortization Expense After Year Four FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour	1537186	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	5738006	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	6100000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	5747000	usd
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	2212000	usd
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	357000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	6104000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	2212000	usd
CY2024Q3	us-gaap	Accounts Payable Trade Current And Noncurrent AccountsPayableTradeCurrentAndNoncurrent	4280299	usd
CY2023Q4	us-gaap	Accounts Payable Trade Current And Noncurrent AccountsPayableTradeCurrentAndNoncurrent	4406299	usd
CY2024Q3	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	761258	usd
CY2023Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	514112	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	5041557	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	4920411	usd
CY2024Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	11882288	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3106508	usd
CY2024Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	301643	usd
CY2024Q3	us-gaap	Long Term Debt LongTermDebt	11580645	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	3106508	usd
CY2024Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	1882598	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	702701	usd
CY2024Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	9698047	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2403807	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	258897	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	2200210	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	3016526	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	5595358	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	534923	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	276374	usd
CY2024Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	11882288	usd
CY2024Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P20Y
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	1019339	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3886340	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	3580109	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2603948	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1919157	usd
CY2024Q3	HCWC	Lessee Operating Lease Liability Payments Due After Year Four LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour	2103882	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	15112775	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1533182	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	13579593	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	13668290	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	11412562	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3360002	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2748824	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	10219591	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8461182	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	916000	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	625000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2354000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1688000	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0496	pure
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0398	pure
CY2024Q3	us-gaap	Payments For Rent PaymentsForRent	1160000	usd
CY2023Q3	us-gaap	Payments For Rent PaymentsForRent	830000	usd
	us-gaap	Payments For Rent PaymentsForRent	3024000	usd
	us-gaap	Payments For Rent PaymentsForRent	2508000	usd
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	835861	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	586247	usd
CY2024Q3	us-gaap	Variable Lease Cost VariableLeaseCost	243970	usd
CY2023Q3	us-gaap	Variable Lease Cost VariableLeaseCost	205355	usd
CY2024Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	80058	usd
CY2023Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	38637	usd
CY2024Q3	us-gaap	Lease Cost LeaseCost	1159889	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	830239	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	2115175	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1742748	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	670506	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	650211	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	237880	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	114802	usd
	us-gaap	Lease Cost LeaseCost	3023561	usd
	us-gaap	Lease Cost LeaseCost	2507761	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	2240000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	1593000	usd
CY2024Q3	us-gaap	Receivables Net Current ReceivablesNetCurrent	100000	usd
CY2023Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	3800000	usd

Files In Submission

Name	View Source	Status
0001493152-24-045161-index-headers.html	Edgar Link	pending
0001493152-24-045161-index.html	Edgar Link	pending
0001493152-24-045161.txt	Edgar Link	pending
0001493152-24-045161-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
hcwc-20240930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
hcwc-20240930_cal.xml	Edgar Link	unprocessable
hcwc-20240930_def.xml	Edgar Link	unprocessable
hcwc-20240930_lab.xml	Edgar Link	unprocessable
hcwc-20240930_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HCWC
HEALTHY CHOICE WELLNESS CORP. Stock $hcwc

2024 Q4 Form 10-Q Financial Statement

#000149315224045161 Filed on November 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HCWC HEALTHY CHOICE WELLNESS CORP. Stock $hcwc

2024 Q4 Form 10-Q Financial Statement

#000149315224045161 Filed on November 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HCWC
HEALTHY CHOICE WELLNESS CORP. Stock $hcwc